Rumbaoa, Reynie P.

HRN: 22-28-23  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/02/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
12/02/2022
12/12/2022
IVT
4.5g
Q12
T/c Sepsis. Severe Anemia Sec To UGIB Sec To NSAID Use
Waiting Final Action 

Indication:  Empirical Escalation    Type of Infection:  BloodstreamIntra-abdominalUnspecified Sepsis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: